Hybrid reference genome assembly for the archetypal Leishmania (Viannia) guyanensis bearing the dsRNA totivirus LRV1
- PMID: 40693767
- PMCID: PMC12352032
- DOI: 10.1128/mra.00992-22
Hybrid reference genome assembly for the archetypal Leishmania (Viannia) guyanensis bearing the dsRNA totivirus LRV1
Abstract
We report a high-quality hybrid genome assembly and annotation for a Leishmania (Viannia) guyanensis line (M4147) expressing a firefly luciferase reporter gene and bearing the totivirus LRV1 strongly implicated in parasite hypervirulence. This reference genome should facilitate the study of infectivity and pathogenesis of cutaneous and severe leishmaniasis.
Keywords: Leishmania guyanensis; South America; Trypanosomatidae; Viannia; comparative genomics; kinetoplastida; mucocutaneous leishmaniasis.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Hybrid reference genome assemblies for Leishmania (Viannia) braziliensis, a primary agent of mucocutaneous leishmaniasis.Microbiol Resour Announc. 2025 Jul 10;14(7):e0131724. doi: 10.1128/mra.01317-24. Epub 2025 Jun 17. Microbiol Resour Announc. 2025. PMID: 40525854 Free PMC article.
-
Leishmania guyanensis M4147 as a new LRV1-bearing model parasite: Phosphatidate phosphatase 2-like protein controls cell cycle progression and intracellular lipid content.PLoS Negl Trop Dis. 2022 Jun 24;16(6):e0010510. doi: 10.1371/journal.pntd.0010510. eCollection 2022 Jun. PLoS Negl Trop Dis. 2022. PMID: 35749562 Free PMC article.
-
Evaluation of itraconazole monotherapy versus its combination with a single dose of pentamidine for treating cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Amazonas state, western Brazilian Amazon.Trop Med Int Health. 2025 Jul 11. doi: 10.1111/tmi.70008. Online ahead of print. Trop Med Int Health. 2025. PMID: 40642881
-
A comprehensive phenotypic and genotypic taxonomic review of Leishmania (Leishmania) poncei n. sp. (Kinetoplastea: Trypanosomatidae): a novel agent of cutaneous (non-ulcerated) and visceral leishmaniasis in Honduras, Central America.Trop Dis Travel Med Vaccines. 2025 Jul 28;11(1):27. doi: 10.1186/s40794-025-00264-1. Trop Dis Travel Med Vaccines. 2025. PMID: 40717096 Free PMC article. Review.
-
Leishmania Viannia guyanensis, LRV1 virus and extracellular vesicles: a dangerous trio influencing the faith of immune response during muco-cutaneous leishmaniasis.Curr Opin Immunol. 2020 Oct;66:108-113. doi: 10.1016/j.coi.2020.08.004. Epub 2020 Aug 30. Curr Opin Immunol. 2020. PMID: 32877837 Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources